Lithium citrate tetrahydrate 1018 mg per 5 mL
RxNorm 250972
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 250972 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: lithium citrate tetrahydrate 1018 mg per 5 mL.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Lithium citrate 204 mg/ML Oral Solution
(Atom ID: 1279790)
SY
Synonym (SY):
Lithium citrate 1018 mg per 5 mL (lithium ion 10.8 mmol) Oral Syrup
(Atom ID: 5476854)
PT
Designated preferred name (PT):
Lithium citrate 203.6 mg/mL oral solution
(Atom ID: 10301036)
SY
Synonym (SY):
Lithium citrate tetrahydrate 1018 mg per 5 mL
(Atom ID: 5476853)
FN
Full form of descriptor (FN):
Product containing precisely lithium citrate 203.6 mg/1 mL conventional release oral solution (clinical drug)
(Atom ID: 10314357)
Patient Education
Lithium
Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lithium is in a class of medications called antimanic agents. It works by decreasing abnormal activity in the brain.
[Learn More]
* Please review the disclaimer below.